Marketing and Sales of AI Solutions 'Saerok', 'Miribom', and 'Yakmeokja' to Domestic Medical Institutions

Dong-A ST announced on the 10th that it has signed a memorandum of understanding (MOU) with medical IT company Dou (DOU) to promote the adoption of artificial intelligence (AI) solutions for hospitals. The agreement was signed on March 9 at 'HIMSS 2026', a healthcare information systems exhibition held in Las Vegas, USA.

Jaehoon Jung, CEO of Dong-A ST (right), and Dongwook Son, CEO of Dowoo, are posing for a commemorative photo. Dong-A ST

Jaehoon Jung, CEO of Dong-A ST (right), and Dongwook Son, CEO of Dowoo, are posing for a commemorative photo. Dong-A ST

View original image

The two companies will work together to expand the introduction of AI-based work support solutions in hospitals across Korea. Dou will provide its AI solutions, while Dong-A ST will be responsible for marketing and sales to domestic medical institutions.


The solutions covered by the agreement include 'Saerok', an AI medical record assistant; 'Miribom', a pre-examination platform; and 'Yakmeokja', a medication management service.


'Saerok' is a system that uses voice recognition to organize medical staff voices from consultation and operating rooms into medical record formats. It features an automatic extraction function for key clinical information. Currently, joint development is underway to link it with Severance Hospital's electronic medical records (EMR). 'Miribom' is a pre-examination platform where AI analyzes referral documents to help medical staff quickly assess a patient's condition. Patients can fill out pre-examination forms on mobile devices before visiting the hospital. 'Yakmeokja' is a service that allows hospitals and patients to share medication information, and patients can set medication reminders through a conversational interface.


Dou is a medical IT company established in 2022 that develops AI solutions to support work in clinical settings.



Dong-A ST is nurturing its digital healthcare business as a new growth area. The company is expanding its related business portfolio with products such as 'HiCardi', a wearable ECG-based patient monitoring platform; 'Dr. Noon', an AI for predicting cardiovascular diseases based on retinal images; and 'CareSens Air', a continuous glucose monitor.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing